248 related articles for article (PubMed ID: 26639637)
21. Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1 alpha,25-dihydroxyvitamin D3.
Atkins GJ; Anderson PH; Findlay DM; Welldon KJ; Vincent C; Zannettino AC; O'Loughlin PD; Morris HA
Bone; 2007 Jun; 40(6):1517-28. PubMed ID: 17395559
[TBL] [Abstract][Full Text] [Related]
22. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
23. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
Cai X; Xing J; Long CL; Peng Q; Humphrey MB
J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
[TBL] [Abstract][Full Text] [Related]
24. Increased levels of sodium chloride directly increase osteoclastic differentiation and resorption in mice and men.
Wu L; Luthringer BJC; Feyerabend F; Zhang Z; Machens HG; Maeda M; Taipaleenmäki H; Hesse E; Willumeit-Römer R; Schilling AF
Osteoporos Int; 2017 Nov; 28(11):3215-3228. PubMed ID: 28849275
[TBL] [Abstract][Full Text] [Related]
25. Vitamin D depletion induces RANKL-mediated osteoclastogenesis and bone loss in a rodent model.
Anderson PH; Sawyer RK; Moore AJ; May BK; O'Loughlin PD; Morris HA
J Bone Miner Res; 2008 Nov; 23(11):1789-97. PubMed ID: 18597628
[TBL] [Abstract][Full Text] [Related]
26. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
[TBL] [Abstract][Full Text] [Related]
27. The androgen receptor has no direct antiresorptive actions in mouse osteoclasts.
Sinnesael M; Jardi F; Deboel L; Laurent MR; Dubois V; Zajac JD; Davey RA; Carmeliet G; Claessens F; Vanderschueren D
Mol Cell Endocrinol; 2015 Aug; 411():198-206. PubMed ID: 25958043
[TBL] [Abstract][Full Text] [Related]
28. Osteoprotegerin deficiency attenuates strontium-mediated inhibition of osteoclastogenesis and bone resorption.
Peng S; Liu XS; Zhou G; Li Z; Luk KD; Guo XE; Lu WW
J Bone Miner Res; 2011 Jun; 26(6):1272-82. PubMed ID: 21611968
[TBL] [Abstract][Full Text] [Related]
29. Endogenous Calcitriol Synthesis Controls the Humoral IgE Response in Mice.
Lindner J; Rausch S; Treptow S; Geldmeyer-Hilt K; Krause T; St-Arnaud R; Arabian A; Radbruch A; Hartmann S; Worm M; Heine G
J Immunol; 2017 Dec; 199(12):3952-3958. PubMed ID: 29109124
[TBL] [Abstract][Full Text] [Related]
30. Bone marrow ablation demonstrates that excess endogenous parathyroid hormone plays distinct roles in trabecular and cortical bone.
Yan J; Sun W; Zhang J; Goltzman D; Miao D
Am J Pathol; 2012 Jul; 181(1):234-44. PubMed ID: 22640808
[TBL] [Abstract][Full Text] [Related]
31. Breast cancer cell line MDA-231 stimulates osteoclastogenesis and bone resorption in human osteoclasts.
Grano M; Mori G; Minielli V; Cantatore FP; Colucci S; Zallone AZ
Biochem Biophys Res Commun; 2000 Apr; 270(3):1097-100. PubMed ID: 10772956
[TBL] [Abstract][Full Text] [Related]
32. Expression of the calcitonin receptor in bone marrow cell cultures and in bone: a specific marker of the differentiated osteoclast that is regulated by calcitonin.
Lee SK; Goldring SR; Lorenzo JA
Endocrinology; 1995 Oct; 136(10):4572-81. PubMed ID: 7664679
[TBL] [Abstract][Full Text] [Related]
33. Cloning of a functional 25-hydroxyvitamin D-1α-hydroxylase in zebrafish (Danio rerio).
Chun RF; Blatter E; Elliott S; Fitz-Gibbon S; Rieger S; Sagasti A; Adams JS; Hewison M
Cell Biochem Funct; 2014 Dec; 32(8):675-82. PubMed ID: 25290078
[TBL] [Abstract][Full Text] [Related]
34. RNAi-mediated silencing of CYP27B1 abolishes 1,25(OH)2D3 synthesis and reduces osteocalcin and CYP24 mRNA expression in human osteosarcoma (HOS) cells.
Anderson PH; Atkins GJ; Findlay DM; Oloughlin PD; Welldon K; Vincent C; Morris HA
J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):601-5. PubMed ID: 17254772
[TBL] [Abstract][Full Text] [Related]
35. Osteoclast 121F antigen expression during osteoblast conditioned medium induction of osteoclast-like cells in vitro: relationship to calcitonin responsiveness, tartrate resistant acid phosphatase levels, and bone resorptive activity.
Collin-Osdoby P; Oursler MJ; Rothe L; Webber D; Anderson F; Osdoby P
J Bone Miner Res; 1995 Jan; 10(1):45-58. PubMed ID: 7747630
[TBL] [Abstract][Full Text] [Related]
36. CD11b promotes the differentiation of osteoclasts induced by RANKL through the spleen tyrosine kinase signalling pathway.
Yang G; Chen X; Yan Z; Zhu Q; Yang C
J Cell Mol Med; 2017 Dec; 21(12):3445-3452. PubMed ID: 28661042
[TBL] [Abstract][Full Text] [Related]
37. Dysregulation of 5-hydroxytryptamine 6 receptor accelerates maturation of bone-resorbing osteoclasts and induces bone loss.
Park KR; Kim EC; Hong JT; Yun HM
Theranostics; 2018; 8(11):3087-3098. PubMed ID: 29896304
[No Abstract] [Full Text] [Related]
38. Osteoprotegerin ligand regulates osteoclast adherence to the bone surface in mouse calvaria.
O'Brien EA; Williams JH; Marshall MJ
Biochem Biophys Res Commun; 2000 Aug; 274(2):281-90. PubMed ID: 10913332
[TBL] [Abstract][Full Text] [Related]
39. Inhibiting wear particles-induced osteolysis with doxycycline.
Zhang C; Tang TT; Ren WP; Zhang XL; Dai KR
Acta Pharmacol Sin; 2007 Oct; 28(10):1603-10. PubMed ID: 17883947
[TBL] [Abstract][Full Text] [Related]
40. Differentiation and functions of osteoclasts and odontoclasts in mineralized tissue resorption.
Sasaki T
Microsc Res Tech; 2003 Aug; 61(6):483-95. PubMed ID: 12879416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
